BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 4007132)

  • 1. Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP.
    Lundin S; Melin P; Vilhardt H
    Experientia; 1985 Jul; 41(7):933-5. PubMed ID: 4007132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin reduces release from vasopressin-neurons and oxytocin-neurons by acting on V2-like receptors.
    Cheng SW; North WG
    Brain Res; 1989 Feb; 479(1):35-9. PubMed ID: 2522339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.
    Matsui K; Kimura T; Ota K; Iitake K; Shoji M; Inoue M; Yoshinaga K
    Endocrinol Jpn; 1985 Aug; 32(4):547-57. PubMed ID: 3936702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous vasopressin modulates activity of oxytocin neurons in homozygous Brattleboro rats.
    Cheng SW; North WG
    Am J Physiol; 1986 Nov; 251(5 Pt 1):E556-62. PubMed ID: 3777164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.
    Saito T; Higashiyama M; Nagasaka S; Sasaki S; Saito T; Ishikawa SE
    Kidney Int; 2001 Oct; 60(4):1266-76. PubMed ID: 11576341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage.
    Shimizu K; Nakao A
    Endocrinol Jpn; 1992 Oct; 39(5):517-23. PubMed ID: 1478192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of release of neurohypophysial hormones by endogenous opioid peptides in pregnant and parturient rats.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Brain Res; 1986 Sep; 382(2):352-9. PubMed ID: 3756522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat.
    Christensen S
    Scand J Clin Lab Invest; 1980 Apr; 40(2):151-7. PubMed ID: 7256183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiuretic effect of perorally administered DDAVP in hydrated humans.
    Vilhardt H; Bie P
    Acta Endocrinol (Copenh); 1984 Apr; 105(4):474-6. PubMed ID: 6720233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the circulating neurohypophysial hormones affect basal or stress induced prolactin (PRL) release in male rats?
    Jurcovicová J; Dobrakovová M; Oprsalová Z; Jezová D; Makara GB; Kvetnanský R
    Endocr Regul; 1991 Sep; 25(3):159-63. PubMed ID: 1764605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial natriuretic factor inhibits the stimulated in-vivo and in-vitro release of vasopressin and oxytocin in the rat.
    Poole CJ; Carter DA; Vallejo M; Lightman SL
    J Endocrinol; 1987 Jan; 112(1):97-102. PubMed ID: 2950195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and oxytocin release as influenced by thyrotropin-releasing hormone in euhydrated and dehydrated rats.
    Ciosek J
    J Physiol Pharmacol; 2002 Sep; 53(3):423-37. PubMed ID: 12369739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP).
    Dunning BE; Moltz JH; Fawcett CP
    Peptides; 1984; 5(5):871-5. PubMed ID: 6390359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP (1-desamino-8-D-arginine vasopressin) clearance rate.
    Stegner H; Artman HG; Leake RD; Fisher DA
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):204-6. PubMed ID: 6495988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vasopressin and its deamino-D-arginine analogue on renin release in the isolated perfused rat kidney.
    Konrads A; Hofbauer KG; Werner U; Gross F
    Pflugers Arch; 1978 Oct; 377(1):81-5. PubMed ID: 569283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue.
    Shimizu K; Nakao A; Nonaka T; Oka H
    Kidney Int; 1984 Dec; 26(6):785-90. PubMed ID: 6533393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin.
    Schriefer JA
    Neuroendocrinology; 1991 Sep; 54(3):185-91. PubMed ID: 1682832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.